Estrella Immunopharma Inc. (ESLA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $16.53M
Last updated: Nov 17, 2026 at 4:28 PM ET
Estrella Immunopharma Inc. (ESLA) Statistics
Estrella Immunopharma (ESLA) has a market cap of $16.53M and an enterprise value of $16.44M. Its share count is up 17.50% from a year earlier.
Total Valuation
Enterprise value is 0.56% below the market cap, as cash exceeds debt.
| Market Cap | $16.53M |
|---|---|
| Enterprise Value | $16.44M |
| Latest price (Nov 17, 2026) | $0.33 |
Key Dates
The next earnings report is expected on Mar 16, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 16, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 85.39% over 52 weeks and trades 37.74% below its 50-day average.
| Beta (1Y) | 1.56 |
|---|---|
| 52-Week Change | -85.39% |
| 1-Month Change | -12.71% |
| 3-Month Change | -54.99% |
| 6-Month Change | -70.91% |
| 5-Year Change | -93.56% |
| Total Return (1Y) | -85.39% |
| Total Return (3Y CAGR) | -35.74% |
| Total Return (5Y CAGR) | -49.35% |
| Max Drawdown (1Y) | -85.19% |
| Max Drawdown (3Y) | -89.70% |
| Sharpe Ratio (1Y) | -1.14 |
| Correlation with SPY (1Y) | 0.14 |
| 50-Day Average | $0.53 |
| 200-Day Average | $0.96 |
| 52-Week Range | $0.24 to $2.27 |
| RSI (14 Days) | 41.0 |
| Average Volume (20 Days) | 1.89M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.11x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 0.11x |
|---|---|
| Quick Ratio | 0.11x |
| Debt / Equity | 0.00x |
Scores
ESLA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Balance Sheet
| Cash and Equivalents | $92.46K |
|---|---|
| Total Debt | $0 |
| Net Cash | $92.46K |
| Net Cash Per Share | $0.00 |
Balance sheet as of Sep 30, 2026.
Dividends and Yields
ESLA does not pay a dividend. Its free cash flow yield is -61.39%.
| FCF Yield | -61.39% |
|---|---|
| Shareholder Yield | 0.00% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About ESLA
What is ESLA's market cap?
Estrella Immunopharma has a market cap of $16.53M. Its enterprise value, which adds debt and subtracts cash, is $16.44M.
How many shares of ESLA are outstanding?
Estrella Immunopharma has 43.59M shares outstanding. The count is up 17.50% from a year earlier.
Does ESLA pay a dividend?
No. Estrella Immunopharma does not pay a dividend.
How much debt does ESLA have?
Estrella Immunopharma has $0 of total debt and $92.46K of cash and equivalents, a net cash position of $92.46K.
ESLA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors